Effects of nitric oxide synthase-3 overexpression on post-translational modifications and cell survival in HepG2 cells

Journal of Proteomics

Volumn 75, Issue 3, 2012, Pages 740-755

  Aguilar Melero, P ^a   Ferrin G ^b   Muntane J ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Carbonylation; Hepatocarcinoma; Nitration; Nitrosylation; Oxidative stress

Indexed keywords

CHAPERONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE PROTEINASE INHIBITOR;

ARTICLE; CARBONYLATION; CELL DEATH; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOSKELETON; GENE OVEREXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NITRATION; NITROSYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEOMICS;

ADENOSINE TRIPHOSPHATE; ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETON; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SERPINS;

EID: 84355162136     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.09.010     Document Type: Article

References (87)

1. Muntane J., la Mata M.D. Nitric oxide and cancer. World J Hepatol 2010, 2:337-344.
2. Martinez-Ruiz A., Lamas S. Two decades of new concepts in nitric oxide signaling: from the discovery of a gas messenger to the mediation of nonenzymatic posttranslational modifications. IUBMB Life 2009, 61:91-98.
3. Leon L., Jeannin J.F., Bettaieb A. Post-translational modifications induced by nitric oxide (NO): implication in cancer cells apoptosis. Nitric Oxide 2008, 19:77-83.
4. Gow A.J., Chen Q., Hess D.T., Day B.J., Ischiropoulos H., Stamler J.S. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem 2002, 277:9637-9640.
5. Dalle-Donne I., Scaloni A., Giustarini D., Cavarra E., Tell G., Lungarella G., et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev 2005, 24:55-99.
6. Souza J.M., Peluffo G., Radi R. Protein tyrosine nitration - functional alteration or just a biomarker?. Free Radic Biol Med 2008, 45:357-366.
7. Dalle-Donne I., Aldini G., Carini M., Colombo R., Rossi R., Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 2006, 10:389-406.
8. Wong C.M., Marcocci L., Liu L., Suzuki Y.J. Cell signaling by protein carbonylation and decarbonylation. Antioxid Redox Signal 2010, 12:393-404.
9. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995, 92:4392-4396.
10. Boyd C.S., Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002, 383:411-423.
11. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994, 54:1352-1354.
12. Shang Z.J., Li J.R. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression. J Oral Pathol Med 2005, 34:134-139.
13. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xie Q.W., et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995, 181:1333-1343.
14. Liu R., Oberley T.D., Oberley L.W. Effects of endothelial nitric oxide synthase gene expression on the tumor biology of human oral carcinoma SCC-25 cells. Cell Growth Differ 1998, 9:239-246.
15. Diaz-Troya S., Najib S., Sanchez-Margalet V. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells. Regul Pept 2005, 125:41-46.
16. Rigas B., Williams J.L. NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action. Nitric Oxide 2008, 19:199-204.
17. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982, 126:131-138.
18. Gonzalez R., Ferrin G., Hidalgo A.B., Ranchal I., Lopez-Cillero P., Santos-Gonzalez M., et al. N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Chem Biol Interact 2009, 181:95-106.
19. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969, 27:502-522.
20. Lepage G., Munoz G., Champagne J., Roy C.C. Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. Anal Biochem 1991, 197:277-283.
21. Jaffrey S.R., Snyder S.H. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001, 2001:p.pl1.
22. Balabanli B., Kamisaki Y., Martin E., Murad F. Requirements for heme and thiols for the nonenzymatic modification of nitrotyrosine. Proc Natl Acad Sci U S A 1999, 96:13136-13141.
23. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 2002, 82:1524-1532.
24. Nardo G., Pozzi S., Mantovani S., Garbelli S., Marinou K., Basso M., et al. Nitroproteomics of peripheral blood mononuclear cells from patients and a rat model of ALS. Antioxid Redox Signal 2009, 11:1559-1567.
25. Tummala H., Jung C., Tiwari A., Higgins C.M., Hayward L.J., Xu Z. Inhibition of chaperone activity is a shared property of several Cu, Zn-superoxide dismutase mutants that cause amyotrophic lateral sclerosis. J Biol Chem 2005, 280:17725-17731.
26. Jones D.P., Carlson J.L., Mody V.C., Cai J., Lynn M.J., Sternberg P. Redox state of glutathione in human plasma. Free Radic Biol Med 2000, 28:625-635.
27. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994, 233:346-357.
28. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996, 9:836-844.
29. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 2003, 305:776-783.
30. Aulak K.S., Koeck T., Crabb J.W., Stuehr D.J. Dynamics of protein nitration in cells and mitochondria. Am J Physiol Heart Circ Physiol 2004, 286:H30-H38.
31. Casoni F., Basso M., Massignan T., Gianazza E., Cheroni C., Salmona M., et al. Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J Biol Chem 2005, 280:16295-16304.
32. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 2002, 32:797-803.
33. Greenacre S.A., Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 2001, 34:541-581.
34. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998, 356:1-11.
35. Shang F., Nowell T.R., Taylor A. Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. Exp Eye Res 2001, 73:229-238.
36. Gregersen N., Bross P. Protein misfolding and cellular stress: an overview. Methods Mol Biol 2010, 648:3-23.
37. McLaughlin M., Vandenbroeck K. The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?. Br J Pharmacol 2011, 162:328-345.
38. Magi B., Ettorre A., Liberatori S., Bini L., Andreassi M., Frosali S., et al. Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation. Cell Death Differ 2004, 11:842-852.
39. Gupta S., Ahmad N., Mukhtar H. Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res 1998, 58:1785-1788.
40. Cappello F., Conway de Macario E., Marasa L., Zummo G., Macario AJ. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther 2008, 7:801-809.
41. Kuramitsu Y., Nakamura K. Current progress in proteomic study of hepatitis C virus-related human hepatocellular carcinoma. Expert Rev Proteomics 2005, 2:589-601.
42. Reverter-Branchat G., Cabiscol E., Tamarit J., Ros J. Oxidative damage to specific proteins in replicative and chronological-aged Saccharomyces cerevisiae: common targets and prevention by calorie restriction. J Biol Chem 2004, 279:31983-31989.
43. Bhattacharyya T., Karnezis A.N., Murphy S.P., Hoang T., Freeman B.C., Phillips B., et al. Cloning and subcellular localization of human mitochondrial hsp70. J Biol Chem 1995, 270:1705-1710.
44. Dundas S.R., Lawrie L.C., Rooney P.H., Murray G.I. Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol 2005, 205:74-81.
45. Wadhwa R., Takano S., Kaur K., Deocaris C.C., Pereira-Smith O.M., Reddel R.R., et al. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer 2006, 118:2973-2980.
46. Yi X., Luk J.M., Lee N.P., Peng J., Leng X., Guan X.Y., et al. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics 2008, 7:315-325.
47. Wadhwa R., Takano S., Robert M., Yoshida A., Nomura H., Reddel R.R., et al. Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem 1998, 273:29586-29591.
48. Wadhwa R., Yaguchi T., Hasan M.K., Mitsui Y., Reddel R.R., Kaul S.C. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp Cell Res 2002, 274:246-253.
49. Huang B., Liao C.L., Lin Y.P., Chen S.C., Wang D.L. S-nitrosoproteome in endothelial cells revealed by a modified biotin switch approach coupled with Western blot-based two-dimensional gel electrophoresis. J Proteome Res 2009, 8:4835-4843.
50. Lopez-Sanchez L.M., Corrales F.J., Gonzalez R., Ferrin G., Munoz-Castaneda J.R., Ranchal I., et al. Alteration of S-nitrosothiol homeostasis and targets for protein S-nitrosation in human hepatocytes. Proteomics 2008, 8:4709-4720.
51. Gething M.J., Sambrook J. Protein folding in the cell. Nature 1992, 355:33-45.
52. Byrjalsen I., Mose Larsen P., Fey S.J., Nilas L., Larsen M.R., Christiansen C. Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma. Mol Hum Reprod 1999, 5:748-756.
53. Koeck T., Fu X., Hazen S.L., Crabb J.W., Stuehr D.J., Aulak K.S. Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. J Biol Chem 2004, 279:27257-27262.
54. Monteiro H.P. Signal transduction by protein tyrosine nitration: competition or cooperation with tyrosine phosphorylation-dependent signaling events?. Free Radic Biol Med 2002, 33:765-773.
55. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
56. Jiang P., Enomoto A., Takahashi M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett 2009, 284:122-130.
57. Gettins P.G. Serpin structure, mechanism, and function. Chem Rev 2002, 102:4751-4804.
58. Kato H., Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977, 40:1621-1628.
59. Pontisso P., Calabrese F., Benvegnu L., Lise M., Belluco C., Ruvoletto M.G., et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 2004, 90:833-837.
60. Giannelli G., Marinosci F., Sgarra C., Lupo L., Dentico P., Antonaci S. Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. Int J Cancer 2005, 116:579-583.
61. Suminami Y., Nagashima S., Vujanovic N.L., Hirabayashi K., Kato H., Whiteside T.L. Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 2000, 82:981-989.
62. Villano G., Quarta S., Ruvoletto M.G., Turato C., Vidalino L., Biasiolo A., et al. Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. Int J Mol Med 2010, 25:137-143.
63. Haynes V., Traaseth N.J., Elfering S., Fujisawa Y., Giulivi C. Nitration of specific tyrosines in FoF1 ATP synthase and activity loss in aging. Am J Physiol Endocrinol Metab 2010, 298:E978-E987.
64. Hill B.G., Darley-Usmar V.M. S-nitrosation and thiol switching in the mitochondrion: a new paradigm for cardioprotection in ischaemic preconditioning. Biochem J 2008, 412:e11-e13.
65. Giulivi C., Kato K., Cooper C.E. Nitric oxide regulation of mitochondrial oxygen consumption I: cellular physiology. Am J Physiol Cell Physiol 2006, 291:C1225-C1231.
66. Souza J.M., Giasson B.I., Chen Q., Lee V.M., Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem 2000, 275:18344-18349.
67. Butterfield D.A., Poon H.F., St Clair D., Keller J.N., Pierce W.M., Klein J.B., et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 2006, 22:223-232.
68. Chavez J., Chung W.G., Miranda C.L., Singhal M., Stevens J.F., Maier C.S. Site-specific protein adducts of 4-hydroxy-2(E)-nonenal in human THP-1 monocytic cells: protein carbonylation is diminished by ascorbic acid. Chem Res Toxicol 2010, 23:37-47.
69. Castegna A., Aksenov M., Aksenova M., Thongboonkerd V., Klein J.B., Pierce W.M., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 2002, 33:562-571.
70. Martinez A., Dalfo E., Muntane G., Ferrer I. Glycolitic enzymes are targets of oxidation in aged human frontal cortex and oxidative damage of these proteins is increased in progressive supranuclear palsy. J Neural Transm 2008, 115:59-66.
71. Moon K.H., Hood B.L., Kim B.J., Hardwick J.P., Conrads T.P., Veenstra T.D., et al. Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats. Hepatology 2006, 44:1218-1230.
72. Newton B.W., Russell W.K., Russell D.H., Ramaiah S.K., Jayaraman A. Liver proteome analysis in a rodent model of alcoholic steatosis. J Proteome Res 2009, 8:1663-1671.
73. Lieber C.S. Biochemical factors in alcoholic liver disease. Semin Liver Dis 1993, 13:136-153.
74. Jackson S., Schaefer J., Middleton B., Turnbull D.M. Characterisation of a novel enzyme of human fatty acid beta-oxidation: a matrix-associated, mitochondrial 2-enoyl-CoA hydratase. Biochem Biophys Res Commun 1995, 214:247-253.
75. Janssen U., Davis E.M., Le Beau M.M., Stoffel W. Human mitochondrial enoyl-CoA hydratase gene (ECHS1): structural organization and assignment to chromosome 10q26.2-q26.3. Genomics 1997, 40:470-475.
76. Yeh C.S., Wang J.Y., Cheng T.L., Juan C.H., Wu C.H., Lin S.R. Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis. Cancer Lett 2006, 233:297-308.
77. Kim H.K., Park W.S., Kang S.H., Warda M., Kim N., Ko J.H., et al. Mitochondrial alterations in human gastric carcinoma cell line. Am J Physiol Cell Physiol 2007, 293:C761-C771.
78. Lii C.K., Lin A.H., Lee S.L., Chen H.W., Wang T.S. Oxidative modifications of proteins by sodium arsenite in human umbilical vein endothelial cells. Environ Toxicol 2011, 26:459-471.
79. Rabek J.P., Boylston W.H., Papaconstantinou J. Carbonylation of ER chaperone proteins in aged mouse liver. Biochem Biophys Res Commun 2003, 305:566-572.
80. Oliver J.D., van der Wal F.J., Bulleid N.J., High S. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 1997, 275:86-88.
81. Caramelo J.J., Parodi A.J. Getting in and out from calnexin/calreticulin cycles. J Biol Chem 2008, 283:10221-10225.
82. Zhang Y., Baig E., Williams D.B. Functions of ERp57 in the folding and assembly of major histocompatibility complex class I molecules. J Biol Chem 2006, 281:14622-14631.
83. Garbi N., Hammerling G., Tanaka S. Interaction of ERp57 and tapasin in the generation of MHC class I-peptide complexes. Curr Opin Immunol 2007, 19:99-105.
84. Lou Y., Basha G., Seipp R.P., Cai B., Chen S.S., Moise A.R., et al. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival. Clin Cancer Res 2008, 14:1494-1501.
85. Chen J.W., Dodia C., Feinstein S.I., Jain M.K., Fisher A.B. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem 2000, 275:28421-28427.
86. Montes-Nieto R., Fuentes-Almagro C.A., Bonilla-Valverde D., Prieto-Alamo M.J., Jurado J., Carrascal M., et al. Proteomics in free-living Mus spretus to monitor terrestrial ecosystems. Proteomics 2007, 7:4376-4387.
87. Hofseth L.J., Hussain S.P., Wogan G.N., Harris C.C. Nitric oxide in cancer and chemoprevention. Free Radic Biol Med 2003, 34:955-968.